THE UNITED STATES OF AMERICA; AS REPRESENTED BY THE SECRETARY; DEPT OF HEALTH AND HUMAN SERVICES
发明人:
Ian Antheni MYLES,Sandip K. DATTA
申请号：
US16522333
公开号：
US20190381112A1
申请日:
2019.07.25
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
